Welcome to CenterNet's CME testing site for Asthma in Children.
This continuing educational activity consists of a 1 hour video with a CME post test and evaluation form.
This activity should take about 1.5 hours to complete. To qualify for credit and receive a Certificate of Completion, the participant should:
1. review the objectives
2. watch the video
3. complete the viewer evaluation, post test, and CME application which are all available online at this website.
If you achieve a score of 70% or more, you will be able to print your CME certificate from this online site.
If you don't manage to achieve a passing score, you are welcome to try again.
If you have any difficulty printing out your certificate, please email cme@centernet-tv.com with your problem.
CME credit is available until May 2004 for this program. No credit will be given after that date.
Good Luck!

Objectives for Asthma in Children
 • Describe the different phenotypes of wheezy syndromes during the first fives years of life
• Explain how early onset of asthma affects symptoms during childhood and into early adult life
• Explain the background and rationale for The Childhood Asthma Management Program (CAMP) clinical trial
• Describe the results of CAMP for both asthma symptoms and pulmonary function
• Describe the unexpected finding of CAMP and the implications of the result for clinical practice
• Describe growth velocity differences between CAMP children treated with inhaled steroid compare to placebo
• Explain the safety profile of asthma therapy regarding somatic development including growth, sexual maturation and bone density
• List some common barriers to clinician-patient communication and to patient adherence to treatment
• Use ten communication skills that enhance patient teaching and identification of barriers to adherence
 

Faculty Disclosures

Name

Grantee/Research

Consultant Speakers Bureau

Director

Stockholder/Optionee
Fernando Martinez, MD none 2,8,13,18,19,21 none none
David Evans, PhD none none none none
Robert Strunk, MD none none none none
Gail Shapiro, MD 1,2,3,4,5,7,11,12,13,14,16,17,
19,20,21,22,23,24,25,26,27,
28,30, NHLBI, NIID		 2,6,9,10,13,15,19,22,25,26,27,
28,29,31		 none none
1. Abbott
2. AstraZeneca
3. Aventis
4. Boehringer Ingelheim
5. Bristol Myers Squibb
6. Ciba
7. Dey Labs
8. DuPont
9. FDA Allergenic Products Advisory Committee
10. FDA Pulmonary Drugs Advisory Committee
11. Fujisawa
12. Genentech
13. Glaxo SmithKline/Glaxo Wellcome
14. Immunex
15. Key
16. Lederle
17. Lilly Research
18. MedImmune
19. Merck

 		 20. Muro
21. Novartis
22. Pfizer
23. Purdue Frederick
24. Sandofi
25. Schering
26. Sepracor
27. TAP Pharmaceuticals
28. 3m Pharmaceuticals
29. UCB Pharma
30. Upjohn
31. Riker
 

Accreditation Information

The NIH/FAES is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

The NIH/FAES designates this educational activity for a maximum of 1.5 hours in category 1 credit for each program (total of 15 hours for entire series) towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES) and The Association of Academic Health Centers (AHC).  The views presented here are those of the Roundtable panel members and not necessarily those of CenterNet, the producer, the Association of Academic Health Centers, the National Heart, Lung and Blood Institute of the National Institutes of Health, or any government agency. Neither the National Heart, Lung and Blood Institute of the National Institutes of Health, nor any other government agency endorse any particular drug or product. Before using or prescribing any product discussed in the video, clinicians should consult the full prescribing information.

 

CME Viewer Evaluation Form
Please complete the Continuing Medical Education online questionnaire.  The evaluation form provides each viewer the opportunity to rate the extent to which the educational objectives were met, the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias and his/her views on future education needs. To indicate your answers use the rating scale shown below by entering the number that represents your answer into the box to the right of each question. To move to the next question use your tab button. When you have completed the evaluation, please click on the "Take test" button at the bottom of the page.

1= none or not at all 2= very little 3= average 4= considerably 5= completely

1. Please rate the degree to which this program's objectives were attained:
• Describe the different phenotypes of wheezy syndromes during the first fives years of life  
• Explain how early onset of asthma affects symptoms during childhood and into early adult life
• Explain the background and rationale for The Childhood Asthma Management Program (CAMP) clinical trial  
• Describe the results of CAMP for both asthma symptoms and pulmonary function
• Describe the unexpected finding of CAMP and the implications of the result for clinical practice
• Describe growth velocity differences between CAMP children treated with inhaled steroid compare to placebo  
• Explain the safety profile of asthma therapy regarding somatic development including growth, sexual maturation and bone density
• List some common barriers to clinician-patient communication and to patient adherence to treatment
• Use ten communication skills that enhance patient teaching and identification of barriers to adherence

2. The quality of the instructional process was an asset to the program.

3. To what extent did participating in this activity enhance your professional effectiveness?

4. Please rate the quality of the graphics.

5. The instructions provided for the post test were clear and easy to follow.

6.  To what extent did the video: 
• Modify your opinion in this field?
• Modify your practice in this field?
• Reinforce your opinions in this field?
• Prepare you for your practice in this field?       

7.  Please rate the level of commercial bias in this educational activity.  

8.  Other topics you would like to see on video:

9.  Comments/suggestions:

Now that you have completed the evaluation, click below to take the test.